FDA Approved: SILDENAFIL CITRATE — Supplemental Application (Mylan Pharmaceuticals Inc.)

View source ↗

Summary

The FDA approved a supplemental NDA for sildenafil citrate filed by Mylan Pharmaceuticals Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction
• Pulmonary Arterial Hypertension

Drugs mentioned

• Sildenafil citrate (Sildenafil citrate)

Snippet

SUPPL AP for SILDENAFIL CITRATE (SILDENAFIL CITRATE)